Silence Therapeutics plc
SLN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $80,572 | $273,946 | $133,178 | $324,906 |
| - Cash | $82,031 | $41,739 | $64,886 | $121,330 |
| + Debt | -$182 | $0 | $60 | $117 |
| Enterprise Value | -$1,641 | $232,207 | $68,352 | $203,693 |
| Revenue | $159 | $224 | $142 | $24,328 |
| % Growth | -29% | 57.7% | -99.4% | – |
| Gross Profit | $95 | $139 | $88 | $22,722 |
| % Margin | 59.7% | 62.1% | 62% | 93.4% |
| EBITDA | -$20,801 | -$22,491 | -$28,271 | $7,193 |
| % Margin | -13,082.4% | -10,040.6% | -19,909.2% | 29.6% |
| Net Income | -$20,958 | -$27,354 | -$28,530 | $14,174 |
| % Margin | -13,181.1% | -12,211.6% | -20,091.5% | 58.3% |
| EPS Diluted | -1.32 | -1.74 | -1.8 | 0.9 |
| % Growth | 24.1% | 3.3% | -300% | – |
| Operating Cash Flow | -$10,891 | -$21,784 | -$12,309 | -$24,864 |
| Capital Expenditures | -$3 | -$48 | -$4 | -$56 |
| Free Cash Flow | -$10,894 | -$21,832 | -$12,313 | -$24,920 |